N@N

ALX, ORBK, SNHY, LGND, PMACA, BMTC Expected To Be Lower After Earnings Releases on Monday

^{Published on 2009-07-28 14:09:57, Last Modified on 2010-12-22 14:37:45 - WOPRAI}
 

July 29, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, August 3rd and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Alexanders (NYSE: ALX), Orbotech (NASDAQ: ORBK), Sun Hydraulics (NASDAQ: SNHY), Ligand Pharmaceuticals (NASDAQ: LGND), PMA Capital (NASDAQ: PMACA) and Bryn Mawr Bank (NASDAQ: BMTC) are all expected to be lower after their earnings are released Monday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Monday:

Symbol Company # of Reports Quarter Release Time

ALX Alexanders Inc August earnings Q2 Before

ORBK Orbotech Ltd. 12 quarters Q2 Before

SNHY Sun Hydraulics Corp August earnings Q2 After

LGND Ligand Pharmaceuticals 12 quarters Q2 After

PMACA PMA Capital Corporation August earnings Q2 After

BMTC Bryn Mawr Bank Corp 12 quarters Q2 After

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Alexanders, Inc. (NYSE: ALX), a real estate investment trust (REIT), engages in leasing, managing, developing, and redeveloping properties in New York City metropolitan area. The companya�s properties include office and retail properties, and shopping centers. As of December 31, 2008, it owned seven properties comprising five operating, one under development, and one to be developed properties. The company has elected to be treated as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income taxes, provided it distributes at least 90% of its REIT taxable income to its shareholders. The company was founded in 1955 and is based in Paramus, New Jersey.

Orbotech Ltd. (NASDAQ: ORBK), together with its subsidiaries, engages in the design, development, manufacture, marketing, and service of production solutions for specialized applications in the supply chain of the electronics industry worldwide. The company provides automated optical inspection (AOI), production and imaging products for specialized applications in the manufacture of printed circuit boards (PCB) and AOI; test and repair systems for flat panel displays; and automatic check reading products enabled through its recognition software and gamma cameras for use in nuclear cardiac imaging. It also markets computer aided manufacturing solutions for PCB production; develops and markets character recognition solution to banks and other financial institutions; and provides technology for Web-based and location-independent data entry for check and forms processing. The company was formerly known as Optrotech Ltd. and changed its name to Orbotech Ltd. in October 1992 as a result of merger with Orbot Systems Ltd. Orbotech was founded in 1981 and is headquartered in Yavne, Israel.

Sun Hydraulics Corporation (NASDAQ: SNHY) and its subsidiaries design, manufacture, and sell screw-in hydraulic cartridge valves and manifolds used in hydraulic systems. Its products include screw-in hydraulic cartridge valves, including electrically actuated and non-electrically actuated products; manifolds that are machined to create threaded cavities and channels; and integrated packages consisting of various cartridges assembled into a custom designed manifold. The companya�s products are used by various capital goods equipment manufacturers to control force, speed, and motion in construction, agricultural, mining, fire and rescue, and other utility equipment, as well as in a range of industrial applications, such as automation machinery, presses, injection molding equipment, and machine tools. It sells its products primarily through independent fluid power distributors. The company has operations in the United States, England, Germany, France, Korea, India, and the Peoplea�s Republic of China. Sun Hydraulics Corporation was founded in 1970 and is based in Sarasota, Florida.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a biotechnology company, focuses on the discovery and development of pharmaceuticals for the critical unmet medical needs in the United States. It offers Avinza for the treatment of chronic pain; and Eltrombopag/Promacta for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP). The companya�s products under food and drug administration review comprise Bazedoxifene and Lasofoxifene to treat osteoporosis; and Eltrombopag/Revolade for the treatment of ITP. Its products under Phase III include Bazedoxifene/Premarin for menopausal symptoms; and Eltrombopag to treat hepatitis C and chronic liver disease. The companya�s products under Phase II consist of PS433540, a dual acting receptor agonist that targets the angiotensin and endothelin receptors; LGD-4665 for the treatment of ITP; Eltrombopag to treat oncology related thrombocytopenia; PS291822 to prevent COPD and asthma; and PS540446 for the treatment of psoriasis and atherosclerosis. Liganda�s products under Phase I comprise Eltrombopag to treat oncology related thrombocytopenia; PS095760 for leukemia; PS386113 and PS873266 for inflammation; PS948115 to treat respiratory diseases; PS248288 for the treatment of metabolic related diseases; and PS178990 for muscle wasting. Its products under preclinical stage consist of BACE inhibitor for the treatment of Alzheimera�s disease; LGD-4033 for muscle wasting; CCR1 antagonist and glucocorticoid receptor modulator for inflammation; Erythropoietin receptor agonist for hematological indications; and receptor modulators for androgen independent prostate cancer. Ligand has research and development collaborations with pharmaceutical companies, including GlaxoSmithKline; Wyeth; Pfizer, Inc.; Schering-Plough Ltd.; Bristol-Myers Squibb Company; Cephalon, Inc.; Celgene Corporation; and Trevena. The company was founded in 1987 and is based in San Diego, California.

PMA Capital Corporation (NASDAQ: PMACA), through its subsidiaries, provides workersa� compensation, as well as commercial property and casualty insurance products and services primarily in the eastern part of the United States. Its commercial property and liability coverages include commercial automobile, commercial multi-peril, general liability, and umbrella coverages for larger and middle market accounts. The company also provides various claims administration, risk management, loss prevention, and related services primarily to self-insured clients, as well as arent-a-captivea� products for certain insureds and associations. It distributes its products through national, regional, and local brokers and agents, as well as through direct sales representatives. The company was founded in 1915 and is headquartered in Blue Bell, Pennsylvania.

Bryn Mawr Bank Corporation (NASDAQ: BMTC) operates as the holding company for The Bryn Mawr Trust Company, which provides various commercial and retail banking services. The company accepts demand, time, and savings deposits; and makes commercial, real estate, and consumer loans, as well as other extensions of credit, including leases. It offers wealth management services, such as trust administration and fiduciary, custody, investment management and advisory, employee benefit account and IRA administration, estate settlement, tax, financial planning, and brokerage services. The company also provides casualty, property, and allied insurance, as well as life insurance, annuities, medical insurance, and accident and health insurance for groups and individuals. In addition, it offers title search and abstract services; mortgage services; equipment leasing services; and financial planning and investment advisory services to high net worth individuals and families. As of December 31, 2008, the company had nine full service branches and seven retirement community offices in Montgomery, Delaware, and Chester counties. Bryn Mawr Bank Corporation was founded in 1889 and is headquartered in Bryn Mawr, Pennsylvania.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.6 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641